神经内分泌瘤-话题@MedSci

#神经内分泌瘤#

10篇内容 | 768人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1538400, encodeId=d21015384008f, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=CSCO 2020丨朱朝晖教授：神经内分泌瘤的PRRT治疗进展和耐药后的对策, objectType=article, longId=201342, objectId=df67201342e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df67201342e3, replyNumber=0, likeNumber=25, createdTime=2020-09-30, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df67201342e3, moduleTitle=CSCO 2020丨朱朝晖教授：神经内分泌瘤的PRRT治疗进展和耐药后的对策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df67201342e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538399, encodeId=9c481538399b4, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=Lancet oncol：因疗效太好，国产药索凡替尼用于晚期胰腺神经内分泌瘤的三期临床试验提前终止！, objectType=article, longId=201127, objectId=84cb20112e76, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84cb20112e76, replyNumber=0, likeNumber=40, createdTime=2020-09-25, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84cb20112e76, moduleTitle=Lancet oncol：因疗效太好，国产药索凡替尼用于晚期胰腺神经内分泌瘤的三期临床试验提前终止！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84cb20112e76)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538398, encodeId=2e4315383989b, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=Lancet oncol：肽受体放射性核素治疗后予以166Ho放射栓塞治疗神经内分泌瘤肝转移灶的效果和安全性, objectType=article, longId=189097, objectId=190818909e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=190818909e25, replyNumber=0, likeNumber=38, createdTime=2020-03-03, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=190818909e25, moduleTitle=Lancet oncol：肽受体放射性核素治疗后予以166Ho放射栓塞治疗神经内分泌瘤肝转移灶的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=190818909e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538397, encodeId=1d9a153839e22, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=Neuroendocrinology：胰腺神经内分泌瘤切除术后糖尿病恶化可增加肿瘤复发风险, objectType=article, longId=187359, objectId=887a18e35913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=887a18e35913, replyNumber=0, likeNumber=28, createdTime=2020-02-05, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=887a18e35913, moduleTitle=Neuroendocrinology：胰腺神经内分泌瘤切除术后糖尿病恶化可增加肿瘤复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=887a18e35913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538396, encodeId=6c3a1538396e6, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=和黄医药治疗非胰腺神经内分泌瘤新药“索凡替尼”中国上市申请获受理, objectType=article, longId=182867, objectId=daaa18286e02, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daaa18286e02, replyNumber=0, likeNumber=26, createdTime=2019-11-14, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daaa18286e02, moduleTitle=和黄医药治疗非胰腺神经内分泌瘤新药“索凡替尼”中国上市申请获受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daaa18286e02)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538395, encodeId=59a3153839518, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=JAMA Surg：为获得小肠神经内分泌瘤准确分期至少需切除8个淋巴结, objectType=article, longId=152893, objectId=974e15289354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=974e15289354, replyNumber=0, likeNumber=40, createdTime=2018-11-08, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=974e15289354, moduleTitle=JAMA Surg：为获得小肠神经内分泌瘤准确分期至少需切除8个淋巴结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=974e15289354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538394, encodeId=aa59153839434, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=无功能性胰腺神经内分泌瘤侵及脾脏一例, objectType=article, longId=150913, objectId=211e150913fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=211e150913fb, replyNumber=0, likeNumber=26, createdTime=2018-10-14, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=211e150913fb, moduleTitle=无功能性胰腺神经内分泌瘤侵及脾脏一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=211e150913fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538393, encodeId=dbe81538393a5, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=性格多变，容易误诊的神经内分泌瘤，你了解多少？, objectType=article, longId=111634, objectId=b18511163466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b18511163466, replyNumber=0, likeNumber=37, createdTime=2017-09-03, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b18511163466, moduleTitle=性格多变，容易误诊的神经内分泌瘤，你了解多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b18511163466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538392, encodeId=008c1538392a4, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=GICS 2014：卡培他滨/替莫唑胺治疗抵抗性神经内分泌瘤效果更好, objectType=article, longId=31093, objectId=5c5431093d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c5431093d1, replyNumber=0, likeNumber=34, createdTime=2014-02-26, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c5431093d1, moduleTitle=GICS 2014：卡培他滨/替莫唑胺治疗抵抗性神经内分泌瘤效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c5431093d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1538391, encodeId=1d2115383912e, content=<a href='/topic/show?id=509ae419838' target=_blank style='color:#2F92EE;'>#神经内分泌瘤#</a>, objectTitle=JAMA Surgery：病灶大小或为无功能性胰腺神经内分泌瘤淋巴结累及的预测因子, objectType=article, longId=24038, objectId=e54f240387f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e54f240387f, replyNumber=0, likeNumber=34, createdTime=2013-09-08, rootId=0, userName=weiz, userId=8c4b12986175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e54f240387f, moduleTitle=JAMA Surgery：病灶大小或为无功能性胰腺神经内分泌瘤淋巴结累及的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e54f240387f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

神经内分泌瘤

2020-05-29

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

CSCO 2020丨朱朝晖教授：神经内分泌瘤的PRRT治疗进展和耐药后的对策

2020-09-30

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

Lancet oncol：因疗效太好，国产药索凡替尼用于晚期胰腺神经内分泌瘤的三期临床试验提前终止！

2020-09-25

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

Lancet oncol：肽受体放射性核素治疗后予以166Ho放射栓塞治疗神经内分泌瘤肝转移灶的效果和安全性

2020-03-03

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

Neuroendocrinology：胰腺神经内分泌瘤切除术后糖尿病恶化可增加肿瘤复发风险

2020-02-05

智者为医08 (审核中...)

前往app查看评论内容

#神经内分泌瘤#

和黄医药治疗非胰腺神经内分泌瘤新药“索凡替尼”中国上市申请获受理

2019-11-14

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

JAMA Surg：为获得小肠神经内分泌瘤准确分期至少需切除8个淋巴结

2018-11-08

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

无功能性胰腺神经内分泌瘤侵及脾脏一例

2018-10-14

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

性格多变，容易误诊的神经内分泌瘤，你了解多少？

2017-09-03

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

GICS 2014：卡培他滨/替莫唑胺治疗抵抗性神经内分泌瘤效果更好

2014-02-26

weiz (审核中...)

前往app查看评论内容

#神经内分泌瘤#

JAMA Surgery：病灶大小或为无功能性胰腺神经内分泌瘤淋巴结累及的预测因子

2013-09-08

科室
- - 订阅+
  - 更多科室
工具
服务